202 related articles for article (PubMed ID: 23852366)
1. STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).
Ritz O; Rommel K; Dorsch K; Kelsch E; Melzner J; Buck M; Leroy K; Papadopoulou V; Wagner S; Marienfeld R; Brüderlein S; Lennerz JK; Möller P
Oncotarget; 2013 Jul; 4(7):1093-102. PubMed ID: 23852366
[TBL] [Abstract][Full Text] [Related]
2. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
3. Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.
Ritz O; Guiter C; Castellano F; Dorsch K; Melzner J; Jais JP; Dubois G; Gaulard P; Möller P; Leroy K
Blood; 2009 Aug; 114(6):1236-42. PubMed ID: 19423726
[TBL] [Abstract][Full Text] [Related]
4. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F
Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251
[TBL] [Abstract][Full Text] [Related]
5. Knock-down of BCL6 / STAT6 sensitizes primary B cell lymphoma cells for treatment with current therapeutic agents.
Häberle MT; Kelsch E; Dorsch K; Möller P; Ritz O
Oncoscience; 2014; 1(4):283-6. PubMed ID: 25594020
[TBL] [Abstract][Full Text] [Related]
6. Targeting STAT6 in PMBL.
Leroy K; Pujals A; Pelletier L
Oncotarget; 2014 Sep; 5(17):7216. PubMed ID: 25277174
[No Abstract] [Full Text] [Related]
7. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets.
Raia V; Schilling M; Böhm M; Hahn B; Kowarsch A; Raue A; Sticht C; Bohl S; Saile M; Möller P; Gretz N; Timmer J; Theis F; Lehmann WD; Lichter P; Klingmüller U
Cancer Res; 2011 Feb; 71(3):693-704. PubMed ID: 21127196
[TBL] [Abstract][Full Text] [Related]
8. STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.
Miloudi H; Leroy K; Jardin F; Sola B
Cell Signal; 2018 Jun; 46():76-82. PubMed ID: 29501729
[TBL] [Abstract][Full Text] [Related]
9. FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.
Xie L; Ritz O; Leithäuser F; Guan H; Färbinger J; Weitzer CD; Gehringer F; Bruederlein S; Holzmann K; Vogel MJ; Möller P; Wirth T; Ushmorov A
Oncotarget; 2014 Jul; 5(14):5392-402. PubMed ID: 24977668
[TBL] [Abstract][Full Text] [Related]
10. LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.
Bertolo C; Roa S; Sagardoy A; Mena-Varas M; Robles EF; Martinez-Ferrandis JI; Sagaert X; Tousseyn T; Orta A; Lossos IS; Amar S; Natkunam Y; Briones J; Melnick A; Malumbres R; Martinez-Climent JA
Br J Haematol; 2013 Sep; 162(5):621-30. PubMed ID: 23795761
[TBL] [Abstract][Full Text] [Related]
11. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
12. Control of the STAT6-BCL6 antagonism by SWAP-70 determines IgE production.
Audzevich T; Pearce G; Breucha M; Günal G; Jessberger R
J Immunol; 2013 May; 190(10):4946-55. PubMed ID: 23589612
[TBL] [Abstract][Full Text] [Related]
13. Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein.
Weniger MA; Gesk S; Ehrlich S; Martin-Subero JI; Dyer MJ; Siebert R; Möller P; Barth TF
Genes Chromosomes Cancer; 2007 Apr; 46(4):406-15. PubMed ID: 17243160
[TBL] [Abstract][Full Text] [Related]
14. The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6.
Hsu YA; Huang CC; Kung YJ; Lin HJ; Chang CY; Lee KR; Wan L
Cancer Lett; 2016 Jun; 375(2):303-312. PubMed ID: 26945968
[TBL] [Abstract][Full Text] [Related]
15. Binding of BAZF and Bc16 to STAT6-binding DNA sequences.
Hartatik T; Okada S; Okabe S; Arima M; Hatano M; Tokuhisa T
Biochem Biophys Res Commun; 2001 Jun; 284(1):26-32. PubMed ID: 11374866
[TBL] [Abstract][Full Text] [Related]
16. Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
Popov SW; Moldenhauer G; Wotschke B; Brüderlein S; Barth TF; Dorsch K; Ritz O; Möller P; Leithäuser F
Cancer Res; 2007 Jul; 67(14):6555-64. PubMed ID: 17638864
[TBL] [Abstract][Full Text] [Related]
17. The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.
Baron BW; Baron RM; Baron JM
Biochim Biophys Acta; 2015 May; 1852(5):742-8. PubMed ID: 25557390
[TBL] [Abstract][Full Text] [Related]
18. PIM Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.
Szydłowski M; Dębek S; Prochorec-Sobieszek M; Szołkowska M; Tomirotti AM; Juszczyński P; Szumera-Ciećkiewicz A
Am J Pathol; 2021 Mar; 191(3):567-574. PubMed ID: 33307035
[TBL] [Abstract][Full Text] [Related]
19. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
20. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
